Influenza vaccination or not?
People with systemic sclerosis are in the risk group for severe influenza if they should be infected.
According the European Center of Disease Prevention and Control there are 2 large risk groups for severe influenza: Older adults and those with chronic medical conditions (in addition particularly those on immunosuppressive treatment).
Further reading can be found here: https://www.ecdc.europa.eu/en/seasonal-influenza/prevention-and-control/vaccines/risk-groups
In 2019 EULAR gave their updated recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.
The recommendation is that all patients with chronic systemic diseases, including systemic sclerosis, are recommended to get the influenza vaccination.
“Non-live vaccines can be safely provided to AIIRD patients (patients with autoimmune inflammatory rheumatic diseases) regardless of underlying therapy, whereas live-attenuated vaccines may be considered with caution. Influenza and pneumococcal vaccination should be strongly considered for the majority of patients with AIIRD.”
Furthermore, the report says that those on immunosuppressive treatment should receive vaccines according to national guidelines. Read the entire report here: https://ard.bmj.com/content/79/1/39
Should you with systemic sclerosis get the influenza vaccination?
Follow your national guidelines and talk to your physician about the possibilities of vaccinations. He knows you and your disease and treatment best. You should discuss this topic with your rheumatologist or primary care physician.
news & events
Watch our highlights video showing some of our great achievements in 2022.
Are you living with diffuse scleroderma?
Would you like to be involved in a clinical study testing a new investigational drug for use in Diffuse Scleroderma?
If so, you may be eligible to take part in the DECODE Scleroderma Study
FESCA is proud to be a partner of a the new This is Living campaign launched last month by Boehringer Ingelheim.